The Multicenter Registry of Patients with Subarachnoid Hemorrhage (MEASURE) is a longitudinal, observational registry that will prospectively enroll patients from all Dutch SAH treatment centers. Patients with aneurysmal subarachnoid hemorrhage (SAH), perimesencephalic SAH, angio-negative SAH and SAH caused by other vascular malformations will be included in the registry. MEASURE is part of the ‘Collaboration for New TReatments of Acute Stroke 2.0’ (CONTRAST 2.0) consortium.
The left-hand menu helps you to navigate through this website and access more information about the registry.

Kind regards,

On behalf of the MEASURE executive committee and the CONTRAST consortium,
Professor H.D. (Jeroen) Boogaarts, MD PhD (neurosurgeon, Radboud University Medical Center, Principal Investigator)
Professor G.J.E. (Gabriël) Rinkel, MD PhD (neurologist, University Medical Center Utrecht, Principal Investigator)
Professor D. (Dagmar) Verbaan, PhD (clinical epidemiologist, Amsterdam University Medical Center, Principal investigator)
M.D.I. (Mervyn) Vergouwen, MD PhD (neurologist, University Medical Center Utrecht, Principal Investigator)
P.B. (Philippine) van Wijngaarden, MD (PhD candidate, University Medical Center Utrecht, Coordinating Investigator)